Showing results (321-330 of 353) with videos related to

Sort By:
Pageof 36
Zhonghua Yi Xue Za Zhi|July 22, 2010
[Experiences of open transperitoneal radical nephrectomy for large renal masses]Xu-dong Yao, Ding-wei Ye, Shi-lin Zhang, et al.
Zhonghua Yi Xue Za Zhi|April 12, 2012
[Efficacy of low dose ketoconazole therapy for Chinese patients with castration resistant prostate cancer]Guo-wen Lin, Ding-wei Ye, Xu-dong Yao, et al.
Scientific Reports|November 8, 2016
MTHFR c.677C>T Inhibits Cell Proliferation and Decreases Prostate Cancer Susceptibility in the Han Chinese Population in ShanghaiJun-Long Wu, Shu-Xian Zhou, Rui Zhao, et al.
Scientific Reports|November 4, 2016
Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese populationYuan-Yuan Qu, Shu-Xian Zhou, Xuan Zhang, et al.
Annals of Medicine|January 17, 2022
Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy responseXi Tian, Wen-Hao Xu, Fu-Jiang Xu, et al.
Biomaterials Advances|May 30, 2026
An Abraxane-based albumin nanoplatform loaded with a STING agonist for synergistic dual immunotherapy of triple-negative breast cancerZhen Cao, Xiao-Jie Wei, Luan-Feng Liao, et al.
Molecular Cancer|March 25, 2023
The function and mechanisms of action of circular RNAs in Urologic CancerZi-Hao Zhang, Yue Wang, Ya Zhang, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2013
[Exploratory analysis of the effect of toxicity of sunitinib on the clinical outcome of patients with advanced renal cell carcinoma]Ya-ping Hong, Xu-dong Yao, Yao Zhu, et al.
Urologic Oncology|May 11, 2010
Tumor cytoreduction results in better response to androgen ablation--a preliminary report of palliative transurethral resection of the prostate in metastatic hormone sensitive prostate cancerXiao-Jian Qin, Chun-Guang Ma, Ding-Wei Ye, et al.
Future Oncology (London, England)|November 12, 2014
A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinomaHong-kai Wang, Hai-liang Zhang, Yao Zhu, et al.
Pageof 36